In EGFR-mutated lung adenocarcinoma, CD73 becomes highly over-expressed and has been shown to have less infiltrating CD4+ T cells compared to non-mutated NSCLC Velez and Burns, 2019; Streicher et al., 2017. Here, EGFR is linked to lung adenocarcinoma.